nitrites has been researched along with Cardiomyopathies in 12 studies
Nitrites: Salts of nitrous acid or compounds containing the group NO2-. The inorganic nitrites of the type MNO2 (where M=metal) are all insoluble, except the alkali nitrites. The organic nitrites may be isomeric, but not identical with the corresponding nitro compounds. (Grant & Hackh's Chemical Dictionary, 5th ed)
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To examine the role of endothelin ETA and ETB receptors in congestive heart failure due to cardiomyopathy, the effect of chronic treatment with selective ETA- and ETB-receptor antagonists (atrasentan and A-192621, respectively), alone and in combination, was assessed on functional and biochemical parameters of 52-week-old Bio 14." | 3.74 | Nonselective ETA/ETB-receptor blockade increases systemic blood pressure of Bio 14.6 cardiomyopathic hamsters. ( Bkaily, G; Carrier, E; D'Orleans-Juste, P; Fecteau, MH; Honoré, JC; Tirapelli, CR, 2008) |
| "Daunorubicin is an anthracycline antitumour agent that can cause severe cardiomyopathy leading to a frequently fatal congestive heart failure." | 1.33 | Cardioprotective effects of subcutaneous ebselen against daunorubicin-induced cardiomyopathy in rats. ( Arafah, MM; Najjar, TA; Saad, SY, 2006) |
| "Liver cirrhosis is associated with enlarged right cardiac chambers." | 1.31 | Modification of cardiac function in cirrhotic patients with and without ascites. ( De Castro, S; Fiore, P; Funaro, S; Lionetti, R; Masini, A; Merli, M; Pulcinelli, G; Riggio, O; Valeriano, V, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cong, W | 1 |
| Niu, C | 1 |
| Lv, L | 1 |
| Ni, M | 1 |
| Ruan, D | 1 |
| Chi, L | 1 |
| Wang, Y | 2 |
| Yu, Q | 1 |
| Zhan, K | 1 |
| Xuan, Y | 1 |
| Tan, Y | 1 |
| Wei, T | 1 |
| Cai, L | 1 |
| Jin, L | 1 |
| Honoré, JC | 1 |
| Carrier, E | 1 |
| Fecteau, MH | 1 |
| Tirapelli, CR | 1 |
| Bkaily, G | 1 |
| D'Orleans-Juste, P | 1 |
| Daiber, A | 1 |
| Gori, T | 1 |
| Münzel, T | 1 |
| Zhu, SG | 1 |
| Kukreja, RC | 1 |
| Das, A | 1 |
| Chen, Q | 1 |
| Lesnefsky, EJ | 1 |
| Xi, L | 1 |
| van de Sandt, AM | 1 |
| Windler, R | 1 |
| Gödecke, A | 1 |
| Ohlig, J | 1 |
| Zander, S | 1 |
| Reinartz, M | 1 |
| Graf, J | 1 |
| van Faassen, EE | 1 |
| Rassaf, T | 1 |
| Schrader, J | 1 |
| Kelm, M | 1 |
| Merx, MW | 1 |
| Tissier, S | 1 |
| Lancel, S | 1 |
| Marechal, X | 1 |
| Mordon, S | 1 |
| Depontieu, F | 1 |
| Scherpereel, A | 1 |
| Chopin, C | 1 |
| Neviere, R | 1 |
| Saad, SY | 1 |
| Najjar, TA | 1 |
| Arafah, MM | 1 |
| Kharlamova, NV | 1 |
| Chasha, TV | 1 |
| Shilova, NA | 1 |
| Kuz'menko, GN | 1 |
| Klimova, OI | 1 |
| Liu, H | 1 |
| Ma, Z | 1 |
| Lee, SS | 1 |
| Valeriano, V | 1 |
| Funaro, S | 1 |
| Lionetti, R | 1 |
| Riggio, O | 1 |
| Pulcinelli, G | 1 |
| Fiore, P | 1 |
| Masini, A | 1 |
| De Castro, S | 1 |
| Merli, M | 1 |
| Coelho-Filho, OR | 1 |
| De Luca, IM | 1 |
| Tanus-Santos, JE | 1 |
| Cittadino, M | 1 |
| Sampaio, RC | 1 |
| Coelho, OR | 1 |
| Hyslop, S | 1 |
| Moreno Júnior, H | 1 |
| Grosse-Brockhoff, F | 1 |
| Grabensee, B | 1 |
12 other studies available for nitrites and Cardiomyopathies
| Article | Year |
|---|---|
Metallothionein Prevents Age-Associated Cardiomyopathy via Inhibiting NF-κB Pathway Activation and Associated Nitrative Damage to 2-OGD.
Topics: Aging; Animals; Apoptosis; Cardiomyopathies; Cytokines; Energy Metabolism; Enzyme Activation; Gene E | 2016 |
Nonselective ETA/ETB-receptor blockade increases systemic blood pressure of Bio 14.6 cardiomyopathic hamsters.
Topics: Animals; Atrasentan; Blood Pressure; Cardiomyopathies; Cricetinae; Endothelin A Receptor Antagonists | 2008 |
Inorganic nitrate therapy improves Doxorubicin-induced cardiomyopathy a new window for an affordable cardiovascular therapy for everyone?
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Dietary Supplements; Doxorubicin; Humans; Mi | 2011 |
Dietary nitrate supplementation protects against Doxorubicin-induced cardiomyopathy by improving mitochondrial function.
Topics: Animals; Antibiotics, Antineoplastic; Cardiomyopathies; Dietary Supplements; Doxorubicin; Electron T | 2011 |
Endothelial NOS (NOS3) impairs myocardial function in developing sepsis.
Topics: Animals; Arterial Pressure; Cardiac Output; Cardiomyopathies; Coronary Circulation; Disease Models, | 2013 |
Calpain inhibitors improve myocardial dysfunction and inflammation induced by endotoxin in rats.
Topics: Animals; Cardiomyopathies; Endotoxins; Glycoproteins; Heart; In Vitro Techniques; Inflammation; Inje | 2004 |
Cardioprotective effects of subcutaneous ebselen against daunorubicin-induced cardiomyopathy in rats.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Aspartate Aminotransferases; Azoles; Cardiomyopa | 2006 |
[The levels of nitrites and medium molecular-weight molecules in the blood of neonatal infants with posthypoxic cardiopathy].
Topics: Cardiomyopathies; Female; Fetal Hypoxia; Humans; Hypertension, Pulmonary; Infant, Newborn; Male; Myo | 2007 |
Contribution of nitric oxide to the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
Topics: Animals; Bile Ducts; Blotting, Western; Cardiomyopathies; Constriction, Pathologic; Cyclic GMP; Cyto | 2000 |
Modification of cardiac function in cirrhotic patients with and without ascites.
Topics: Ascites; Cardiomyopathies; Case-Control Studies; Echocardiography; Echocardiography, Doppler, Color; | 2000 |
Pravastatin reduces myocardial lesions induced by acute inhibition of nitric oxide biosynthesis in normocholesterolemic rats.
Topics: Analysis of Variance; Animals; Anticholesteremic Agents; Cardiomyopathies; Disease Models, Animal; E | 2001 |
[Therapeutic modification of contractility under clinical conditions].
Topics: Adrenergic beta-Antagonists; Calcium; Cardiomyopathies; Catecholamines; Digitalis Glycosides; Glucag | 1976 |